AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8740786 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 1696
Study 8740786 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus Tamoxifen
Number of subjects: 1696
Study 8740786 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 1696
Study 8740786 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients (excluding opposite-breast and skin tumors)
Number of subjects: 1696
Study 8740786 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen-treated patients (excluding opposite-breast and skin tumors)
Number of subjects: 1696
Study 8740786 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy-treated patients (excluding opposite-breast and skin tumors)
Number of subjects: 1696
Study 8740786 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus Tamoxifen (excluding opposite-breast and skin tumors)
Number of subjects: 1696
Study 1826883 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alpha-human ANP (initial bolus of 0.5 micrograms/kg followed by a 21-min maintenance infusion at 0.05 micrograms.kg-1.min-1)
Number of subjects: 12
Study 1826883 — intervention group
Group type: COMPARATOR
Intervention: Saline intravenous infusion (control group)
Number of subjects: 12
Study 7040929 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 200 mg/m2 followed by 5-fluorouracil (5-FU) 600 mg/m2
Number of subjects: 30
Study 7040929 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 40 mg/m2 followed by 5-fluorouracil (5-FU) 600 mg/m2
Number of subjects: 30
Study 31350870 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical insulin-liposomal gel
Number of subjects: 80
Study 31350870 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 80
Study 30303973 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric Core Training (ICT)
Number of subjects: 19
Study 30303973 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Core Training (DCT)
Number of subjects: 19
Study 26291554 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV
Number of subjects: 189
Study 26291554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study 25044402 — intervention group
Group type: EXPERIMENTAL
Intervention: safinamide 50 mg/d
Number of subjects: 0
Study 25044402 — intervention group
Group type: EXPERIMENTAL
Intervention: safinamide 100 mg/d
Number of subjects: 0
Study 25044402 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 25044402 — intervention group
Group type: EXPERIMENTAL
Intervention: safinamide (both dosages)
Number of subjects: 0
Study 25044402 — intervention group
Group type: COMPARATOR
Intervention: safinamide and placebo
Number of subjects: 0
Study 22475083 — intervention group
Group type: COMPARATOR
Intervention: Immediate test ordering
Number of subjects: 498
Study 22475083 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchful waiting
Number of subjects: 498
Study 22475083 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchful waiting with quality improvement strategy
Number of subjects: 498
Study 20576162 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-sensitive moxibustion
Number of subjects: 0
Study 20576162 — intervention group
Group type: COMPARATOR
Intervention: Conventional moxibustion
Number of subjects: 0
Study 20576162 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug treatment (intra-articular Sodium Hyaluronate injection)
Number of subjects: 0
Study 18019591 — intervention group
Group type: EXPERIMENTAL
Intervention: Active console video games
Number of subjects: 21
Study 18019591 — intervention group
Group type: COMPARATOR
Intervention: Nonactive console video games
Number of subjects: 21
Study 16117450 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet gel (APG) application during cardiovascular surgery
Number of subjects: 0
Study 12125181 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-derived preparations for symptomatic treatment of obstipation, irritable bowel, and inflammatory bowel disease
Number of subjects: 0
Study 12125181 — intervention group
Group type: COMPARATOR
Intervention: Phytotherapeutic preparations
Number of subjects: 0
Study 9924589 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent oral polio vaccine (TOPV) in Group A (vaccinated at 34-35 weeks)
Number of subjects: 62
Study 9924589 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent oral polio vaccine (TOPV) in Group B (vaccinated at 38-40 weeks)
Number of subjects: 62
Study 9924589 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C: term babies vaccinated in the 1st week of life)
Number of subjects: 62
Study 7987981 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study 7987981 — intervention group
Group type: COMPARATOR
Intervention: Control (no tamoxifen)
Number of subjects: 0
Study 3338259 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐[3H]noradrenaline infusion
Number of subjects: 19
Study 29653120 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully covered self-expandable metal stent (FCSEMS)
Number of subjects: 158
Study 29653120 — intervention group
Group type: COMPARATOR
Intervention: Uncovered self-expandable metal stent (USEMS)
Number of subjects: 158
Study 26460721 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibreoptic intubation
Number of subjects: 80
Study 26460721 — intervention group
Group type: COMPARATOR
Intervention: Trachway®
Number of subjects: 80
Study 24967372 — intervention group
Group type: EXPERIMENTAL
Intervention: Action observation (AO) coupled with upper limb training
Number of subjects: 67
Study 24967372 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 67
Study 22825085 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 338
Study 22825085 — intervention group
Group type: COMPARATOR
Intervention: Structured education program
Number of subjects: 338
Study 21080780 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 2314
Study 21080780 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents
Number of subjects: 2314
Study 21080780 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 2314
Study 18775266 — intervention group
Group type: EXPERIMENTAL
Intervention: NIOX analyser (Group 1, n = 30)
Number of subjects: 60
Study 18775266 — intervention group
Group type: EXPERIMENTAL
Intervention: NIOX-MINO analyser (Group 2, n = 30)
Number of subjects: 60
Study 15830219 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45 g/kg alcohol
Number of subjects: 17
Study 15830219 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.65 g/kg alcohol
Number of subjects: 17
Study 15830219 — intervention group
Group type: COMPARATOR
Intervention: Alcohol expectancy (placebo)
Number of subjects: 17
Study 15830219 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 17
Study 12888589 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin extended-release formulation (1000 mg once daily for five consecutive days)
Number of subjects: 42
Study 11782036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox regression with time‐dependent covariates including time elapsed since last observation (TEL)
Number of subjects: 0
Study 11782036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox regression with time‐dependent covariates
Number of subjects: 0
Study 9246981 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime (1.5 g single injection)
Number of subjects: 40
Study 9246981 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 40
Study 8352456 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation for 6 months
Number of subjects: 16
Study 8352456 — intervention group
Group type: COMPARATOR
Intervention: Olive oil supplementation for 6 months
Number of subjects: 16
Study 3101777 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (intravenous boluses)
Number of subjects: 6
Study 3101777 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline (antagonist to adenosine)
Number of subjects: 6
Study 2655625 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 100
Study 2655625 — intervention group
Group type: COMPARATOR
Intervention: Medical air
Number of subjects: 100
Study 30764699 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic subjects with HFpEF
Number of subjects: 53
Study 30764699 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic subjects with HFpEF
Number of subjects: 53
Study 28089225 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised treatment
Number of subjects: 90
Study 28089225 — intervention group
Group type: COMPARATOR
Intervention: Group treatment
Number of subjects: 90
Study 26267985 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ergocalciferol (double dosage from K/DOQI recommendations)
Number of subjects: 68
Study 26267985 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose ergocalciferol (as recommended by K/DOQI guidelines)
Number of subjects: 68
Study 22818512 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol brief interventions (BIs)
Number of subjects: 1219
Study 21175612 — intervention group
Group type: EXPERIMENTAL
Intervention: +BRT
Number of subjects: 100
Study 21175612 — intervention group
Group type: COMPARATOR
Intervention: -BRT
Number of subjects: 100
Study 19164441 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical removal of colloid cysts
Number of subjects: 38
Study 19164441 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 38
Study 17280678 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) 8 mg/day
Number of subjects: 136
Study 17280678 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 136
Study 16396714 — intervention group
Group type: COMPARATOR
Intervention: Nailfold capillaroscopy (NFC) in children with MCTD
Number of subjects: 118
Study 16396714 — intervention group
Group type: COMPARATOR
Intervention: Nailfold capillaroscopy (NFC) in children with SLE
Number of subjects: 118
Study 16396714 — intervention group
Group type: COMPARATOR
Intervention: Nailfold capillaroscopy (NFC) in children with JDM
Number of subjects: 118
Study 16396714 — intervention group
Group type: COMPARATOR
Intervention: Nailfold capillaroscopy (NFC) in children with JSSc
Number of subjects: 118
Study 16396714 — intervention group
Group type: COMPARATOR
Intervention: Nailfold capillaroscopy (NFC) in children with JIA
Number of subjects: 118
Study 16396714 — intervention group
Group type: EXPERIMENTAL
Intervention: Nailfold capillaroscopy (NFC) in connective tissue diseases
Number of subjects: 118
Study 11172152 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine treatment
Number of subjects: 176
Study 9270631 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged regimen of prophylaxis with ticarcillin/clavulanate for 2 days and low-dose vancomycin until removal of the intraaortic balloon pump (n = 28)
Number of subjects: 53
Study 9270631 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 25)
Number of subjects: 53
Study 9270631 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged regimen of prophylaxis with ticarcillin/clavulanate and low-dose vancomycin (n = 28)
Number of subjects: 53
Study 8175538 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled furosemide (45 +/- 3 mg)
Number of subjects: 8
Study 8175538 — intervention group
Group type: COMPARATOR
Intervention: Inhaled saline (S + HV)
Number of subjects: 8
Study 8175538 — intervention group
Group type: COMPARATOR
Intervention: Hyperventilation (HV)
Number of subjects: 8
Study 3284271 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (5 micrograms/kg before tracheal intubation, 5 micrograms/kg before skin incision, and 2 micrograms/kg each 15 min during the 1st hour)
Number of subjects: 28
Study 3284271 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fentanyl)
Number of subjects: 28
Study 3284271 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 28
Study 30932053 — intervention group
Group type: EXPERIMENTAL
Intervention: Amyg‐EFP‐NF
Number of subjects: 180
Study 30932053 — intervention group
Group type: COMPARATOR
Intervention: Control-EEG-NF
Number of subjects: 180
Study 30932053 — intervention group
Group type: COMPARATOR
Intervention: NoNF
Number of subjects: 180
Study 28329184 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracing by peer health workers
Number of subjects: 5781
Study 28329184 — intervention group
Group type: COMPARATOR
Intervention: Not randomly selected (Control)
Number of subjects: 5781
Study 26216410 — intervention group
Group type: EXPERIMENTAL
Intervention: Embryo transfer at 2 cm distance from the fundal endometrium (DFE)
Number of subjects: 195
Study 26216410 — intervention group
Group type: COMPARATOR
Intervention: Embryo transfer at the midpoint of the endometrial cavity length (ECL)
Number of subjects: 195
Study 26216410 — intervention group
Group type: EXPERIMENTAL
Intervention: Embryo transfer at 2 cm DFE
Number of subjects: 195
Study 26216410 — intervention group
Group type: COMPARATOR
Intervention: Embryo transfer at the midpoint of the ECL
Number of subjects: 195
Study 23219061 — intervention group
Group type: EXPERIMENTAL
Intervention: Focussed narrative interview
Number of subjects: 100
Study 23219061 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 21943180 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion plus usual care
Number of subjects: 20
Study 21943180 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20
Study 18349212 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulating catheter (SC) technique
Number of subjects: 82
Study 18349212 — intervention group
Group type: COMPARATOR
Intervention: Nonstimulating catheter (NSC) technique
Number of subjects: 82
Study 18349212 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SC and NSC techniques
Number of subjects: 82
Study 16517384 — intervention group
Group type: COMPARATOR
Intervention: Traditional training from experienced instructors
Number of subjects: 31
Study 16517384 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented feedback on specific biomechanical aspects of spinal manipulation therapy using an instrumented manikin
Number of subjects: 31
Study 12709737 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (6 mg loading dose over 48 hours plus 2 mg/day maintenance) + low-dose cyclosporine (8 mg/kg/day)
Number of subjects: 12
Study 12709737 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus + low-dose cyclosporine
Number of subjects: 12
Study 11010949 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-fiber diet (50% soluble fiber and 50% insoluble fiber)
Number of subjects: 8
Study 11010949 — intervention group
Group type: COMPARATOR
Intervention: Insoluble-fiber diet
Number of subjects: 8
Study 11010949 — intervention group
Group type: COMPARATOR
Intervention: Fiber-free diet
Number of subjects: 8
Study 11010949 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-fiber diet
Number of subjects: 8
Study 8797619 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparinized central venous catheters (n = 13)
Number of subjects: 55
Study 8797619 — intervention group
Group type: COMPARATOR
Intervention: Control central venous catheters (n = 19)
Number of subjects: 55
Study 1518121 — intervention group
Group type: EXPERIMENTAL
Intervention: Panipenem/betamipron (PAPM/BP) administered at 10 mg/10 mg/kg
Number of subjects: 52
Study 1518121 — intervention group
Group type: EXPERIMENTAL
Intervention: Panipenem/betamipron (PAPM/BP) administered at 20 mg/20 mg/kg
Number of subjects: 52
Study 1518121 — intervention group
Group type: EXPERIMENTAL
Intervention: Panipenem/betamipron (PAPM/BP) administered at 31.3 mg/31.3 mg/kg
Number of subjects: 52
Study 1518121 — intervention group
Group type: EXPERIMENTAL
Intervention: Panipenem/betamipron (PAPM/BP) administered in various doses (5.2 mg/5.2 mg to 31.3 mg/31.3 mg/kg)
Number of subjects: 52
Study 6375540 — intervention group
Group type: EXPERIMENTAL
Intervention: simethicon ‐ pankreatin
Number of subjects: 750
Study 6375540 — intervention group
Group type: EXPERIMENTAL
Intervention: lysin‐vasopressin
Number of subjects: 750
Study 6375540 — intervention group
Group type: EXPERIMENTAL
Intervention: filling of the stomach with soup and erect position
Number of subjects: 750
Study 6375540 — intervention group
Group type: EXPERIMENTAL
Intervention: prone position
Number of subjects: 750
Study 6375540 — intervention group
Group type: EXPERIMENTAL
Intervention: dimethicon
Number of subjects: 750
Study 31367741 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline
Number of subjects: 0
Study 31367741 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 0
Study 31367741 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline and Moxifloxacin
Number of subjects: 0
Study 30551561 — intervention group
Group type: EXPERIMENTAL
Intervention: Upgraded case payment (intervention group)
Number of subjects: 0
Study 30551561 — intervention group
Group type: EXPERIMENTAL
Intervention: County level hospital (intervention group)
Number of subjects: 0
Study 27461049 — intervention group
Group type: EXPERIMENTAL
Intervention: ¡Cocinar Para Su Salud! (n = 34), a culturally based 9-session program (24 hours over 12 weeks)
Number of subjects: 70
Study 27461049 — intervention group
Group type: EXPERIMENTAL
Intervention: ¡Cocinar Para Su Salud! (n = 34)
Number of subjects: 70
Study 27461049 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 36, written dietary recommendations for breast cancer survivors)
Number of subjects: 70
Study 24423431 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D3/d
Number of subjects: 83
Study 24423431 — intervention group
Group type: COMPARATOR
Intervention: 400 IU vitamin D3/d
Number of subjects: 83
Study 22280547 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT)
Number of subjects: 41
Study 20209395 — intervention group
Group type: EXPERIMENTAL
Intervention: Early appendicectomy for appendicular mass
Number of subjects: 506
Study 20209395 — intervention group
Group type: COMPARATOR
Intervention: Conservative management for appendicular mass
Number of subjects: 506
Study 19033604 — intervention group
Group type: EXPERIMENTAL
Intervention: Tango dance program (10 weeks, 40 hours, 2 hours twice a week)
Number of subjects: 30
Study 19033604 — intervention group
Group type: COMPARATOR
Intervention: Walking program (10 weeks, 40 hours, 2 hours twice a week)
Number of subjects: 30
Study 16298597 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 19
Study 16298597 — intervention group
Group type: COMPARATOR
Intervention: Wash-out period (discontinuing diltiazem)
Number of subjects: 19
Study 12431802 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH
Number of subjects: 15
Study 12431802 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-6
Number of subjects: 15
Study 12431802 — intervention group
Group type: EXPERIMENTAL
Intervention: ghrelin
Number of subjects: 15
Study 10413263 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision training (complex instruction, variable practice, reduced delayed feedback)
Number of subjects: 0
Study 10413263 — intervention group
Group type: COMPARATOR
Intervention: Behavioural training (simple-to-complex instruction, variable practice, abundant feedback)
Number of subjects: 0
Study 7585841 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 204,636 (25 to 250 mg/d)
Number of subjects: 12
Study 7585841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2186067 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal biofeedback with adjunctive relaxation training (TBF)
Number of subjects: 116
Study 2186067 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal biofeedback plus cognitive therapy
Number of subjects: 116
Study 2186067 — intervention group
Group type: COMPARATOR
Intervention: Pseudomeditation as an ostensible attention‐placebo control
Number of subjects: 116
Study 2186067 — intervention group
Group type: COMPARATOR
Intervention: Headache monitoring
Number of subjects: 116
Study 657994 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole (55.5 mg/kg)
Number of subjects: 100
Study 657994 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole (52.0 mg/kg)
Number of subjects: 100
Study 657994 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 100
Study 657994 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 100
Study 31394314 — intervention group
Group type: EXPERIMENTAL
Intervention: Bouncing Image Training Task (BITT) - daily sessions for one week
Number of subjects: 113
Study 31394314 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 113
Study 27093861 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions (3 fractions per week)
Number of subjects: 80
Study 25662989 — intervention group
Group type: EXPERIMENTAL
Intervention: MN-RSh (RSh group)
Number of subjects: 45
Study 25662989 — intervention group
Group type: COMPARATOR
Intervention: MN-CAS (CAS group)
Number of subjects: 45
Study 23397236 — intervention group
Group type: EXPERIMENTAL
Intervention: Young adult participants exposed to misleading suggestions from older adult confederates
Number of subjects: 0
Study 23397236 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adult participants exposed to misleading suggestions from older adult confederates
Number of subjects: 0
Study 23397236 — intervention group
Group type: EXPERIMENTAL
Intervention: Young and older adult participants
Number of subjects: 0
Study 20079480 — intervention group
Group type: EXPERIMENTAL
Intervention: MIST‐VR
Number of subjects: 46
Study 20079480 — intervention group
Group type: COMPARATOR
Intervention: D‐Box
Number of subjects: 46
Study 18211118 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC 50 microg/100 microg
Number of subjects: 458
Study 18211118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 458
Study 16939559 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing mean HbA1c from 9.5% to 8.0%
Number of subjects: 0
Study 16939559 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing mean HbA1c from 8.0% to 7.0%
Number of subjects: 0
Study 16939559 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing mean HbA1c from 7.0% to 6.5%
Number of subjects: 0
Study 16939559 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential reduction scenarios
Number of subjects: 0